164 related articles for article (PubMed ID: 38456897)
1. Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.
Nagayama Y; Hayashi H; Taguchi N; Yoshida R; Harai R; Kidoh M; Oda S; Nakaura T; Hirai T
Abdom Radiol (NY); 2024 May; 49(5):1626-1637. PubMed ID: 38456897
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT.
Liu T; Sun H; Zhang H; Duan J; Hu Y; Xie S
Br J Radiol; 2019 Feb; 92(1094):20180429. PubMed ID: 30433826
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
Choi YA; Kim CK; Park BK; Kim B
Radiology; 2013 Feb; 266(2):514-20. PubMed ID: 23151828
[TBL] [Abstract][Full Text] [Related]
4. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
[TBL] [Abstract][Full Text] [Related]
6. Adrenal metastases: early biphasic contrast-enhanced CT findings with emphasis on differentiation from lipid-poor adrenal adenomas.
Zhu F; Zhu X; Shi H; Liu C; Xu Z; Shao M; Tian F; Wang J
Clin Radiol; 2021 Apr; 76(4):294-301. PubMed ID: 33509608
[TBL] [Abstract][Full Text] [Related]
7. Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.
Nagayama Y; Inoue T; Oda S; Tanoue S; Nakaura T; Ikeda O; Yamashita Y
Radiology; 2020 Aug; 296(2):324-332. PubMed ID: 32452733
[TBL] [Abstract][Full Text] [Related]
8. Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas.
Kim MJ; Kang KA; Kim CK; Park SY
Eur Radiol; 2023 Mar; 33(3):2218-2226. PubMed ID: 36173446
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection.
Kumagae Y; Fukukura Y; Takumi K; Shindo T; Tateyama A; Kamiyama T; Kamimura K; Nakajo M
Clin Radiol; 2013 Jul; 68(7):696-703. PubMed ID: 23482305
[TBL] [Abstract][Full Text] [Related]
10. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
[TBL] [Abstract][Full Text] [Related]
11. Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
Nagayama Y; Inoue T; Kato Y; Tanoue S; Kidoh M; Oda S; Nakaura T; Hirai T
Radiology; 2021 Nov; 301(2):360-368. PubMed ID: 34463552
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
[TBL] [Abstract][Full Text] [Related]
13. Determination of a cutoff attenuation value on single-phase contrast-enhanced CT for characterizing adrenal nodules via chemical shift MRI.
Wu YW; Tan CH
Abdom Radiol (NY); 2016 Jun; 41(6):1170-7. PubMed ID: 26830419
[TBL] [Abstract][Full Text] [Related]
14. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT--10-minute delayed imaging protocol revisited in a large patient cohort.
Sangwaiya MJ; Boland GW; Cronin CG; Blake MA; Halpern EF; Hahn PF
Radiology; 2010 Aug; 256(2):504-10. PubMed ID: 20656838
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of Adrenal Hyperplasia From Adenoma by Use of CT Densitometry and Percentage Washout.
Park SY; Park BK; Park JJ; Kim CK
AJR Am J Roentgenol; 2016 Jan; 206(1):106-12. PubMed ID: 26700341
[TBL] [Abstract][Full Text] [Related]
16. Inter-individual comparison of diagnostic accuracy of adrenal washout CT compared to chemical shift MRI plus the T2-weighted (T2W) adrenal MRI calculator in indeterminate adrenal masses: a retrospective non-inferiority study.
McPhedran R; Gerson R; Alfaleh H; Sathiadoss P; Schieda N
Abdom Radiol (NY); 2022 Jul; 47(7):2453-2461. PubMed ID: 35536326
[TBL] [Abstract][Full Text] [Related]
17. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas.
Schieda N; Krishna S; McInnes MDF; Moosavi B; Alrashed A; Moreland R; Siegelman ES
AJR Am J Roentgenol; 2017 Sep; 209(3):W152-W159. PubMed ID: 28742373
[TBL] [Abstract][Full Text] [Related]
18. CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma.
Park SY; Park BK; Park JJ; Kim CK
Abdom Imaging; 2015 Feb; 40(2):310-7. PubMed ID: 25060750
[TBL] [Abstract][Full Text] [Related]
19. Adenoma characterization: adrenal protocol with dual-energy CT.
Kim YK; Park BK; Kim CK; Park SY
Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
[TBL] [Abstract][Full Text] [Related]
20. The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results.
Romeo V; Maurea S; Guarino S; Mainenti PP; Liuzzi R; Petretta M; Cozzolino I; Klain M; Brunetti A
Abdom Radiol (NY); 2018 Aug; 43(8):2119-2129. PubMed ID: 29214448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
